Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey

Summary The objective of the EXAMINE‐AF study was to record and compare antithrombotic treatment in patients with atrial fibrillation (AF) in daily clinical practice of general practitioners, internists and cardiologists in the Netherlands. Eighty‐six general practitioners, 93 internists and 99 card...

Full description

Saved in:
Bibliographic Details
Published in:International journal of clinical practice (Esher) 2007-01, Vol.61 (1), p.24-31
Main Authors: Dinh, T., Nieuwlaat, R., Tieleman, R. G., Büller, H. R., Van Charante, N. A. Mensing, Prins, M. H., Crijns, H. J. G. M.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Atrial Fibrillation - drug therapy
Attitude of Health Personnel
Biological and medical sciences
Cardiac dysrhythmias
Cardiology
Cardiology. Vascular system
Drug Prescriptions
Family Practice
Female
Fibrinolytic Agents - therapeutic use
General aspects
Guideline Adherence
Heart
Humans
Internship and Residency
Male
Medical sciences
Middle Aged
Netherlands
Practice Guidelines as Topic
Risk Factors
Surveys and Questionnaires
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary The objective of the EXAMINE‐AF study was to record and compare antithrombotic treatment in patients with atrial fibrillation (AF) in daily clinical practice of general practitioners, internists and cardiologists in the Netherlands. Eighty‐six general practitioners, 93 internists and 99 cardiologists responded to postal questionnaires and enrolled 1596 patients: 365, 351 and 880 respectively. A cardiologist was indicated to be the main treating physician for AF in 82% of all patients; current antithrombotic treatment was initiated in 80% by a cardiologist. Of all patients, 84% were at high risk for stroke and therefore were eligible for oral anticoagulation treatment, but only 64% actually received this. Cardiologists instituted appropriate antithrombotic treatment best, compared with general practitioners and internists (70% vs. 58% and 55%; p 
ISSN:1368-5031
1742-1241
DOI:10.1111/j.1742-1241.2006.01241.x